Danfeng Dong

1.0k total citations
26 papers, 485 citations indexed

About

Danfeng Dong is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Danfeng Dong has authored 26 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Danfeng Dong's work include Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (7 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Danfeng Dong is often cited by papers focused on Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (7 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Danfeng Dong collaborates with scholars based in China and United States. Danfeng Dong's co-authors include Yibing Peng, Zhen Li, Lihua Zhang, Cen Jiang, Xuefeng Wang, Cen Jiang, Enqiang Mao, Qi Ni, Yuan Tian and Lihua Zhang and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Critical Care.

In The Last Decade

Danfeng Dong

25 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danfeng Dong China 15 272 227 185 38 37 26 485
Hans C. van Leeuwen Netherlands 13 318 1.2× 258 1.1× 198 1.1× 31 0.8× 31 0.8× 18 643
Mohammed El‐Mowafy Egypt 12 259 1.0× 234 1.0× 141 0.8× 23 0.6× 71 1.9× 28 606
Longxian Lv China 15 232 0.9× 305 1.3× 106 0.6× 49 1.3× 32 0.9× 27 599
Alissa J. Rivera United States 10 232 0.9× 488 2.1× 82 0.4× 70 1.8× 69 1.9× 13 743
Tetsuo Yamaguchi Japan 14 302 1.1× 205 0.9× 109 0.6× 27 0.7× 11 0.3× 45 501
Jianguo Tang China 13 131 0.5× 163 0.7× 123 0.7× 57 1.5× 34 0.9× 30 447
Steven J. Mileto Australia 7 301 1.1× 146 0.6× 132 0.7× 20 0.5× 20 0.5× 11 444
Loubna Alavoine France 6 130 0.5× 122 0.5× 66 0.4× 23 0.6× 24 0.6× 9 435
Miloš Korać Serbia 9 124 0.5× 239 1.1× 323 1.7× 23 0.6× 38 1.0× 26 567
Sajid Nadeem India 12 227 0.8× 306 1.3× 97 0.5× 32 0.8× 33 0.9× 17 518

Countries citing papers authored by Danfeng Dong

Since Specialization
Citations

This map shows the geographic impact of Danfeng Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danfeng Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danfeng Dong more than expected).

Fields of papers citing papers by Danfeng Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danfeng Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danfeng Dong. The network helps show where Danfeng Dong may publish in the future.

Co-authorship network of co-authors of Danfeng Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Danfeng Dong. A scholar is included among the top collaborators of Danfeng Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danfeng Dong. Danfeng Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wei, Yichen Zhao, Liang Hu, et al.. (2025). Madecassoside alleviates Clostridioides difficile infection by targeting ASC to inhibit inflammasome activation. International Immunopharmacology. 165. 115440–115440.
2.
Dong, Danfeng, Lili Xu, Mengqi Xie, et al.. (2023). Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis. Critical Care. 27(1). 127–127. 56 indexed citations
3.
Cui, Yingchao, Clarissa J. Nobile, Danfeng Dong, et al.. (2023). Systematic identification and characterization of five transcription factors mediating the oxidative stress response in Candida albicans. Microbial Pathogenesis. 187. 106507–106507. 7 indexed citations
4.
Ni, Qi, Xianwei Wu, Cen Jiang, et al.. (2023). The regulatory subunits of CK2 complex mediate DNA damage response and virulence in Candida Glabrata. BMC Microbiology. 23(1). 317–317. 1 indexed citations
5.
Dong, Danfeng, Wei Chen, Cen Jiang, et al.. (2023). Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment. Gut Microbes. 15(1). 2192478–2192478. 30 indexed citations
6.
Wang, Xuefeng, et al.. (2022). Assessment of patient based real‐time quality control on comparative assays for common clinical analytes. Journal of Clinical Laboratory Analysis. 36(9). e24651–e24651. 12 indexed citations
7.
Du, Yuzhang, Juanjuan Zheng, Yue Song, et al.. (2022). ATF3 Positively Regulates Antibacterial Immunity by Modulating Macrophage Killing and Migration Functions. Frontiers in Immunology. 13. 839502–839502. 16 indexed citations
8.
Dong, Danfeng, et al.. (2022). Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5. FEBS Open Bio. 12(10). 1747–1760. 6 indexed citations
9.
Wu, Yinying, et al.. (2020). Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review. Therapeutic Advances in Medical Oncology. 12. 3863555972–3863555972. 7 indexed citations
10.
Cui, Yingchao, Danfeng Dong, Lihua Zhang, et al.. (2019). Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China. BMC Infectious Diseases. 19(1). 961–961. 17 indexed citations
11.
Dong, Danfeng, et al.. (2018). GPR108, an NF-κB activator suppressed by TIRAP, negatively regulates TLR-triggered immune responses. PLoS ONE. 13(10). e0205303–e0205303. 16 indexed citations
12.
Ni, Qi, Chen Wang, Yuan Tian, et al.. (2018). CgPDR1 gain‐of‐function mutations lead to azole‐resistance and increased adhesion in clinical Candida glabrata strains. Mycoses. 61(7). 430–440. 27 indexed citations
15.
Jiang, Cen, Zhen Li, Lihua Zhang, et al.. (2016). Significance of hyphae formation in virulence of Candida tropicalis and transcriptomic analysis of hyphal cells. Microbiological Research. 192. 65–72. 26 indexed citations
16.
Ni, Qi, Yuan Tian, Lihua Zhang, et al.. (2016). Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China. Diagnostic Microbiology and Infectious Disease. 86(4). 428–433. 24 indexed citations
17.
Dong, Danfeng, Zhen Li, Lihua Zhang, et al.. (2015). Clinical and Microbiological Investigation of Fungemia from Four Hospitals in China. Mycopathologia. 179(5-6). 407–414. 14 indexed citations
18.
Zhang, Lihua, Danfeng Dong, Cen Jiang, et al.. (2015). Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization. Anaerobe. 34. 1–7. 101 indexed citations
19.
Dong, Danfeng, Xu Chen, Cen Jiang, et al.. (2013). Genetic analysis of Tn916-like elements conferring tetracycline resistance in clinical isolates of Clostridium difficile. International Journal of Antimicrobial Agents. 43(1). 73–77. 24 indexed citations
20.
Li, Yi, Hui Guo, Danfeng Dong, Huili Wu, & Enxiao Li. (2013). Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma. Diagnostic Pathology. 8(1). 207–207. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026